Therefore, due to the interaction of these two markers in the activation of AR and the spread of malignant progression, we attempted to identify different phenotypes with regard to MAGE-A6 and MAGE-A11 expressions in BC tissues. This evidence concerns the gene MAGEA11 and breast cancer.